Serum Magnesium Levels and Cardiovascular Outcomes in Systolic Blood Pressure Intervention Trial Participants-Reference-Cited by-同舟云学术

Serum Magnesium Levels and Cardiovascular Outcomes in Systolic Blood Pressure Intervention Trial Participants

Published:2023-06 Issue:6 Volume:5 Page:100634
ISSN:2590-0595
Container-title:Kidney Medicine
language:en
Short-container-title:Kidney Medicine

Author:

Ferrè Silvia,Liu Yu-Lun,Lambert Joshua W.,Katz Ronit,Gianella Fabiola G.,Drew David A.,Shlipak Michael G.,Moe Orson W.,Ix Joachim H.,Toto Robert D.,Neyra Javier A.

Publisher

Elsevier BV

Subject

Nephrology,Internal Medicine

Reference36 articles.

1. Serum and dietary magnesium and risk of ischemic stroke: the Atherosclerosis Risk in Communities Study;Ohira;Am J Epidemiol,2009

2. Is low magnesium concentration a risk factor for coronary heart disease? the Atherosclerosis Risk in Communities (ARIC) Study;Liao;Am Heart J,1998

3. Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study;Peacock;Am Heart J,2010

4. Serum magnesium and the risk of death from coronary heart disease and sudden cardiac death;Kieboom;J Am Heart Assoc,2016

5. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study;Khan;Circulation,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the Mechanisms of Magnesium Supplementation in Alleviating Chronic Kidney Disease Complications and Progression: Balancing Risks and Benefits;Biological Trace Element Research;2024-09-10

2. Ionized and total magnesium levels in patients with chronic kidney disease: associated factors and outcomes;Clinical Kidney Journal;2024-02-23